Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -86.25% is 47% below its 5-year average of -58.73%, near the low end of its 5-year range (-86.25%–-37.57%).
24.40% below its 12-month average of -69.34%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -32.09%.
RETURN ON ASSETS (ROA)
-86.25%
RETURN ON ASSETS (ROA) AVG TTM
-69.34%
RETURN ON ASSETS (ROA) AVG 3Y
-63.87%
RETURN ON ASSETS (ROA) AVG 5Y
-58.73%
RETURN ON ASSETS (ROA) AVG 10Y
-91.88%
RETURN ON ASSETS (ROA) AVG 15Y
-96.50%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.40%
CURRENT VS 3Y AVG
-35.04%
CURRENT VS 5Y AVG
-46.87%
CURRENT VS 10Y AVG
+6.13%
CURRENT VS 15Y AVG
+10.62%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.75%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-171.65%
vs the sector median at left
InspireMD, Inc.
Market Cap
$26.23M
Return on Assets (ROA)
-86.25%
TTM Avg
-69.34%
3Y Avg
-63.87%
5Y Avg
-58.73%
Market Cap
$25.91M
Return on Assets (ROA)
-56.04%
TTM Avg
-32.94%
3Y Avg
-18.68%
5Y Avg
-12.05%
Market Cap
$27.45M
Return on Assets (ROA)
-22.11%
TTM Avg
-50.36%
3Y Avg
-51.04%
5Y Avg
-41.44%
Market Cap
$24.79M
Return on Assets (ROA)
-116.81%
TTM Avg
-53.20%
3Y Avg
-39.87%
5Y Avg
-35.95%
Market Cap
$24.61M
Return on Assets (ROA)
-40.73%
TTM Avg
-51.29%
3Y Avg
-88.21%
5Y Avg
-85.48%
Market Cap
$28.22M
Return on Assets (ROA)
-87.08%
TTM Avg
-72.41%
3Y Avg
-58.48%
5Y Avg
-50.84%
Market Cap
$23.92M
Return on Assets (ROA)
181.24%
TTM Avg
65.61%
3Y Avg
3.99%
5Y Avg
-7.40%
Market Cap
$29.48M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
Market Cap
$29.54M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $26.23M | -86.25% | -69.34% | -63.87% | -58.73% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.91M | -56.04% | -32.94% | -18.68% | -12.05% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.45M | -22.11% | -50.36% | -51.04% | -41.44% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.79M | -116.81% | -53.20% | -39.87% | -35.95% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.61M | -40.73% | -51.29% | -88.21% | -85.48% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.22M | -87.08% | -72.41% | -58.48% | -50.84% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.92M | 181.24% | 65.61% | 3.99% | -7.40% |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -102.56% | -232.33% | -191.42% | -176.42% |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | -99.62% | -39.99% | -67.06% | 188.84% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.93M | -75.43% | -148.63% | -74.35% | -49.59% |
ROA
-86.3%
ROE
-122.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -70.29% |
| 2024-12-31 | -68.38% |
| 2023-12-31 | -41.80% |
| 2022-12-31 | -75.01% |
| 2021-12-31 | -37.57% |
| 2020-12-31 | -59.31% |
| 2019-12-31 | -101.62% |
| 2018-12-31 | -58.92% |
| 2017-12-31 | -138.17% |
| 2016-12-31 | -89.91% |
| 2015-12-31 | -269.73% |
| 2014-12-31 | -219.00% |
| 2013-12-31 | -141.04% |
| 2012-06-30 | -109.89% |
| 2011-12-31 | -140.13% |
| 2010-06-30 | -403.36% |
| 2009-06-30 | -77.66% |
